Topical Hydrocortisone for TMJ Pain
Topical Treatment for TMJ Arthralgia
Recruiting
Phase 3
Interventional Study
TMJ Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- University of the Pacific · Other
Who this trial is looking for
This trial is looking for people with pain in their jaw joint for at least 3 days. Participants will apply a cream to the affected area four times a day for 21 days and report their pain and jaw function at the start and end of the trial.
Are You a Good Fit for This Trial?
You may be able to join if
- I have pain in at least one jaw joint for at least 3 days
You may not be able to join if
- I have a systemic pain condition
- I have had an allergic reaction to steroids in the past
- I am currently taking a steroid
- I have taken a steroid in the past ___ months
- I am taking muscle relaxants
- I got a new night guard during the study, or within 1 month of starting the study
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in TMJ arthralgia. The main questions it aims to answer are:
* How does pain reduction compare?
* How does improvement in jaw function limitation compare?
* How do side effects compare? Participants will
* On day 1 be examined and report their pain level and jaw function limitation
* On days 1-21, apply the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Arthralgia of at least 1 TMJ for at least 3 days
Exclusion Criteria:
* Systemic pain condition
* Past adverse reaction to steroid
* Currently taking steroid
* Taken steroid in the past \_\_\_ months
* Muscle relaxants (may start after study is complete)
* New night guard dur…
Contacts